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Intra-Extra Dimensional Set-Shift (IED) testPre-frontal cortical (PFC) dysfunction has been put forward as the basis for development and maintenance of
addiction. To explore this relationship, the present study investigated the effects of smoking on PFC-mediated
cognitive ﬂexibility and subjective states in low- (LD) and high-dependent (HD) smokers.
Twenty-four LD and 24 HD smokers (Fagerström dependence scores≤4 and≥5, respectively) were randomly
allocated to non-smoking or smoking condition (12 LD and 12 HD participants per condition). After abstaining
from smoking for a minimum of two hours volunteers completed a battery of questionnaires [nicotine-
speciﬁc Visual Analogue Scales (Nic-VAS), Questionnaire of Smoking Urges (QSU) and Proﬁle of Mood States
(POMS)] at baseline [T1] and again after smoking one cigarette or remaining abstinent [T2]. Cognitive
ﬂexibility was evaluated at T2 using the Intra-Extra Dimensional Set-Shift test. The Rapid Visual Information
Processing test was performed as a control nicotine-sensitive task at several time points during the
experiment.
Compared to LD smokers, HD smokers had higher salivary cotinine and breath CO levels at baseline and
reported more craving (QSU) and felt less stimulated (Nic-VAS), vigorous, friendly and elated (POMS)
throughout the experiment. Smoking increased Nic-VAS ratings of ‘Buzzed’ and ‘Dizzy’ and decreased craving
in all participants. Smoking selectively impaired cognitive ﬂexibility in HD smokers since HD smokers
allocated to the smoking condition made signiﬁcantly more errors with the intra-dimensional set-shift than
their counterparts in the abstinent condition. No effect of smoking on RVIP test was observed, most likely due
to the practice effect which was signiﬁcant in both groups of smokers. The practice effect, however, was more
pronounced in LD smokers.
This study demonstrates that PFC-mediated cognitive effects of smoking as well as subjective reports vary
according to the degree of nicotine dependence..
@brighton.ac.uk (A. Jackson).
 license.© 2011 Elsevier Inc. Open access under CC BY license.1. Introduction
Pre-frontal cortical (PFC) dysfunction has been put forward as the
basis for development and maintenance of drug addiction (Kalivas
and Volkow, 2005). According to Goldstein and Volkow (2002), drug
addiction can be deﬁned as ‘a syndrome of impaired response
inhibition and salience attribution’ (p. 1643), and is thought to stem
from the reduced inhibitory control of behavior by pre-frontal
structures, which accentuates behavior driven by motivationally
signiﬁcant stimuli. In support of this view, abstinent drug abusers
were found to display impairments in several components of frontal
executive cognitive function compared to healthy controls (Verdejo-
Garcia et al., 2004, 2005, 2006; Kim et al., 2005; von Geusau et al.,
2004; Ornstein et al., 2000; Paul et al., 2006), as well as to show
reduced glucose utilization in the PFC, which was correlated with the
extent of the cognitive impairment (Kim et al., 2005). These ﬁndings,however, are not unequivocal and a few studies reported no
difference (Verdejo-Garcia and Pérez-Garcia, 2007; Johanson et al.,
2006) or even better performance (Hoff et al., 1996) of substance
abusers relative to healthy controls in tests of executive function.
While abusers of cannabis, stimulants and heroin have been shown
to suffer from impairments in frontal executive function, as exhibited by
reduced cognitive ﬂexibility (Lundqvist, 2005; Ornstein et al., 2000;
Verdejo-Garcia et al., 2005), very little data exists regarding cognitive
ﬂexibility in smokers. Reports of a negative relationship between the
severity of smoking dependence and cognitive ﬂexibility in adolescent
psychiatric patients (Martin et al., 2000) as well as in healthy middle-
aged individuals (Kalmijn et al., 2002) suggest that pre-frontal
dysfunction may also be implicated in nicotine abuse. The ﬁndings
from both of these studies (Martin et al., 2000; Kalmijn et al., 2002),
however, were only correlational and smoking satiation was not
experimentally manipulated — subjects were tested in a no-smoking
environment. It is therefore possible that the observed cognitive
impairments were due to nicotine withdrawal and that the heavier
smokers had the greatest impairments due to the greatest severity of
withdrawal. On the other hand, in a controlled abstinence study,
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between healthy non-smokers and smokers who were abstinent for
30 min. In addition, Mancuso et al. (1999) found no effect of nicotine
patch on cognitive ﬂexibility in heavy smokers who were abstinent for
two hours prior to testing. The task used in the latter study, however,
only measured reversal learning and not the more complex executive
function that is involved in attentional set-shifting.
Although very few studies have examined the effects of smoking/
nicotine administration on cognitive ﬂexibility, the enhancing effects
of nicotine have been successfully demonstrated in a number of
studies of sustained attention and effortful or strategic cognitive
processing (e.g. Bell et al., 1999; Domier et al., 2007; Warburton and
Arnall, 1994; Le Houezec et al., 1994; Snyder and Henningﬁeld, 1989;
Tait et al., 2000; Foulds et al., 1996; Levin et al., 1998). While in most
of these studies the positive cognitive effects of nicotine have been
interpreted in terms of the reversal of withdrawal-induced deﬁcits
(Bell et al., 1999; Snyder and Henningﬁeld, 1989; Tait et al., 2000;
Domier et al., 2007), cognitive enhancement seen in minimally- or
non-deprived smokers (Warburton and Arnall, 1994; Lawrence et al.,
2002; Rycroft et al., 2005, 2006) as well as in non-smokers (Le
Houezec et al., 1994; Foulds et al., 1996; Levin et al., 1998; Rusted and
Trawley, 2006; Rusted and Alvares, 2008; Marchant et al., 2008;
Holmes et al., 2008) suggests that nicotine does indeed facilitate some
aspects of cognitive processing.
Smoking-induced cognitive enhancement, however, has not been
consistently demonstrated across studies. For example, West and
Hack (1991) reported smoking-induced improvement in performance
on a complex information processing test (Sternberg memory search
paradigm) both in occasional (mean 1.4 cigarettes per day) and in
regular smokers (mean 14.6 cigarettes per day). In contrast, another
study examining the performance of abstinent and non-abstinent
smokers (≥20 cigarettes per day) on the Sternberg task found that
both groups of smokers performed worse than the non-smokers
(Spilich et al., 1992), with non-abstinent smokers performing the
worst. The importance of the level of smoking dependence in
determining the cognitive effects of smoking has further been
demonstrated in a study by Tait et al. (2000), who observed a
signiﬁcant improvement in cognitive processing after smoking in
previously abstinent heavy but not light smokers. Recently, Azizian
et al. (2008) failed to demonstrate smoking-related improvement in
perceptual–motor test performance which may have been due to the
observed negative correlation between the severity of smoking
dependence and the task performance across the two conditions
(smoking and abstinent). Taken together, these studies suggest that
the degree of dependence may be a factor that interacts with the
experimental manipulation as to obscure the acute effect of smoking.
The outcome of cognitive studies is further complicated by the fact
that the selection criteria used for participant selection in smoking
research vary, withmany studies focusing on number of cigarettes per
day (e.g. Spilich et al., 1992; Tait et al., 2000; Mancuso et al., 1999).
However, this is not always the most appropriate indicator of nicotine
dependence (Etter and Perneger, 2001). For example, an individual
may smoke 10–15 cigarettes per day and yet have a low dependence
score because he or she has the ﬁrst cigarette of the day several hours
after waking and smokes mostly later in the day and in the evening,
when socializing with friends. Conversely, another individual may
smoke only 5–6 cigarettes per day and yet be in the habit of smoking
ﬁrst thing in the morning and regularly throughout the day. A more
complex measure of dependence, the score derived from the
Fagerström Tolerance Questionnaire (FTQ; Fagerström, 1978), incor-
porates other aspects of smoking behavior in addition to the number
of cigarettes and thus may be more appropriate to detect the
differences between low- and high-dependent smokers.
The aim of the present study was to investigate the acute effects of
smoking on cognitive ﬂexibility in low- and high-dependent smokers,
as deﬁned by the FTQ score. The test of pre-frontal executive functionused in the present studywas the Intra-Extra Dimensional Set Shifting
task (IED), a computerized equivalent of the Wisconsin Card Sorting
Test (WCST). The IED test consists of nine consecutive stages with
increasing level of complexity and it measures two components of
executive function: reversal learning (ability to inhibit a habitual
response) and attentional ﬂexibility (intra-dimensional and extra-
dimensional set-shift stages). Different stages of the task have been
found to promote activity in different regions of the PFC (Rogers et al.,
2000), the extra-dimensional shift stage being the stage most
sensitive to frontal lobe damage (Owen et al., 1991). In addition to
the IED test, participants in this study also performed a Rapid Visual
Information Processing (RVIP) test as a cognitive control task sensitive
to nicotine effects (e.g. Warburton and Arnall, 1994; Foulds et al.,
1996; Jackson et al., 2009).
2. Method
2.1. Subjects
Forty eight volunteers aged 18–35 (mean±SEM: 23.3±0.4) and
smoking 1–30 cigarettes per day (mean±SEM: 11.5±1.1) were
recruited from staff and students at Universities of Brighton and Sussex.
They were ﬂuent in English, generally healthy and not taking any
medication at the time of the testing session. Volunteers were recruited
on the basis of their smoking dependence score, as measured by the
Fagerström Tolerance Questionnaire (FTQ; Fagerström, 1978), and
allocated to either low-dependent (LD; FTQ score≤4; 12 male, 12
female; 1–15 cigarettes per day) or high-dependent smoker group (HD;
FTQ score≥5; 12 male, 12 female; 5–30 cigarettes per day). The cut-off
points for the two groups represent the 33rd and the 66th percentile
FTQ score of a sample of 181 smokerswhohad completed the FTQ either
for previous smoking studies at the University of Brighton or when
joining the University of Brighton Psychopharmacology laboratory
volunteer database. Because of a very small range of scores on the FTQ
(minimum1,maximum11) and because themajority of smokers in our
population had scores between 3 and 7, the 33rd percentile was 4,
whichwas the same as themedian,while the 66th percentilewas 5.Half
of each FTQ group was then randomly allocated to the smoking (S)
condition and half to the abstinent (NS) condition (groups balanced for
gender).
Volunteers were instructed to refrain from smoking for at least 2 h
prior to the testing session and were told that compliance would be
veriﬁed by administration of a Smokerlyzer test. They were asked to
avoid using illicit drugs for at least one week, sleeping pills and other
sedatives for 48 h and alcohol for 12 h before the testing session.
Additionally, they were asked to abstain from consuming caffeinated
drinks for one hour before the start of the testing session. At the
beginning of the experiment volunteers received an information sheet
which stated that the purpose of the study was to investigate the
subjective and cognitive effects of smoking. They were informed that
they may be asked to smoke one of their own cigarettes during the
testing session. All volunteers gave their written informed consent to
take part in the study and received £8 at the end of the testing session.
This study was approved by the School of Pharmacy and Biomolecular
Sciences Research Ethics Committee at the University of Brighton in
compliance with the Declaration of Helsinki for the use of human
participants.
2.2. Experimental design
Volunteers were tested individually in a between-subjects design,
fully balanced for gender and the smoking dependence level, with the
between-subjects factors being smoking condition (abstinent—NS vs.
smoking — S) and FTQ group (low-dependent — LD vs. high-
dependent — HD). In order to assess temporal changes during the
course of the experimental session, ‘time point’ was introduced as a
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variables were subjective effects, mood, craving for cigarettes, breath
CO and RVIP test performance (2 time points: baseline and post-
smoking) as well as cognitive ﬂexibility measurements (one time
point: post-smoking).
2.3. Materials and measures
2.3.1. Demographic questionnaire
In addition to the FTQ and the questions about the onset and
duration of smoking habit, demographic questionnaires included the
Alcohol Use Questionnaire (AUQ; Mehrabian and Russell, 1978) and
the Drug Use Questionnaire (DUQ; Nesic and Duka, unpublished). The
AUQ is a self-report questionnaire which establishes the average
weekly alcohol intake and patterns of drinking behavior over a 6-
month period. The DUQ is a self-report questionnaire which
establishes life-time as well as frequency of current use of illicit
drugs, including amphetamines, cocaine, MDMA, opiates, hallucino-
gens and cannabis. Each of the drugs included in the DUQ is scored as
follows: 0=never used, 1=not used in the last month, 2=used once
in the last month, 3=used 2–5 times in the last month, 4=used 6–10
times in the last month, and 5=used more than 10 times in the last
month (with the exception of cannabis, which is scored as follows:
0=never smoked, 1=not smoked in the last month, 2=smoked
once in the last month, 3=smoked≤once a week in the last month,
4=smoked several times a week in the last month, and 5=smoked
every day in the last month). Analysis is performed on each individual
item as well as on the total drug use score which is obtained by adding
up all the scores for individual drug items. This DUQwas developed in
our laboratory and it has been used for drug screening purposes in a
number of studies involving social drinkers (Nesic and Duka, 2006,
2008) and smokers (Nesic et al., unpublished).
2.3.2. Physiological measurements
2.3.2.1. Salivary cotinine level. Each volunteer provided one saliva
sample by gently chewing on a cotton swab for 2 min. The swab was
then placed in a vial and stored at −20 °C until analysis. Cotinine
measurements were obtained from only 14 LD and 21 HD volunteers
since two saliva samples were contaminated with blood and another
11 did not provide a validmeasurement. Sampleswere analyzed using
salivary cotinine quantitative enzyme immunoassay kit (Salimetrics).
The minimal concentration of cotinine that can be distinguished using
this method is .05 ng/ml and the measurements obtained are highly
correlated with measurements obtained using liquid chromatography
method (r2=.901, pb .001; Dhar, 2004).
2.3.2.2. Breath CO level. Breath carbon-monoxide (CO) level (ppm)
was measured using Bedfont Smokerlyzer CO monitor.
2.3.3. Subjective measurements
2.3.3.1. Nicotine-related Visual Analogue Scales (nicotine-VAS). A list of
nicotine-related subjective effects was presented and volunteers were
instructed to answer how much each adjective described how they
felt at that moment by placing a mark on the bipolar visual analogue
scales (VAS — 100 mm) with the poles ‘not at all’ on the left and
‘extremely’ on the right. The adjectives were ‘stimulated’, ‘buzzed’,
‘impatient’, ‘alert’, ‘irritable’, ‘jittery’, ‘dizzy’, ‘relaxed’ and ‘hungrier
than usual’ (Jackson et al., 2009 — based on Perkins et al., 1999).
2.3.3.2. Proﬁle of Mood States questionnaire (POMS). POMS is a list of 72
mood-related adjectives, which are rated on a 5-point scale, ranging
from “not at all” [0] to “extremely” [4] (McNair et al., 1971). These items
are grouped into 8 basic factors (Anxiety, Depression, Anger, Vigour,
Fatigue, Confusion, Friendliness and Elation) as well as two compositescores, Arousal [(Anxiety+Vigour)−(Fatigue+Confusion)] and Pos-
itive Mood (Elation−Depression) (de Wit and Doty, 1994).
2.3.3.3. Questionnaire of Smoking Urges (QSU). The brief version of QSU
consists of 10 questions designed to measure desire to smoke and
anticipation of positive outcome (factor 1: positive reinforcement) as
well as strong urge to smoke and anticipation of relief of withdrawal
(factor 2: negative reinforcement) (Cox et al., 2001). The volunteers
were required to rate how much each statement applied to them at
that particular moment by writing a mark on a Likert-type 7-point
scale, ranging from ‘strongly disagree’ (1) to ‘strongly agree’ (7).
2.3.4. Cognitive assessment
2.3.4.1. Intra-Extra Dimensional Set-Shift test (IED). The IED (Cambridge
Neuropsychological Test Automated Battery, Cambridge Cognition) is a
computerized touch-screen test of rule acquisition and reversal, which
begins as a simple visual discrimination task and then gradually
increases in the degree of complexity. The display features two stimuli
in the form of shapes and/or shapes and lines that appear randomly in
two of the four possible locations on the computer screen. Initially,
volunteers are required to learn a simple discrimination (i.e., which of
the two shapes is correct), then simple reversal (i.e., change of
contingencies, where the previously incorrect shape becomes correct)
and then to attend to the correct shape even when the stimuli become
more complex by the addition of the lines. Subsequently a new pair of
the compound shape-line stimuli appears and volunteers are required
to maintain attention to shapes and to ignore the lines (stage 6 — the
intra-dimensional [ID] shift). Finally, in stage 8, another new pair of
compound stimuli appears and volunteers are now required to switch
their attention to the previously irrelevant dimension, the lines (the
extra-dimensional [ED] shift). At no point during the test do the
participant receive any instructions about the change of rules and thus
the learning is entirely feedback-based (signal for ‘right’ or ‘wrong’ at
the end of each trial). If a participant makes twenty ﬁve errors at any
particular stage, the task is terminated prematurely. The main outcome
measures derived from this test are the number of stages completed (1–
9), total number of errors on the test as well as the number of errors
made on each of the nine blocks. Additional two composite outcome
measures were analyzed: attentional ﬂexibility (errors in stages 6+8)
and reversal learning where the same rule applies but the previously
incorrect stimulus becomes correct (errors in stages 2+5+7+9).
2.3.4.2. Rapid Visual Information Processing (RVIP) test. A ﬁve-minute
RVIP test (Jackson et al., 2009 — based on Wesnes and Warburton,
1984) was administered using E-Prime 1.1 software and a response
box (Psychology Software Tools Inc). Volunteers were required to
monitor a continuous stream of digits, presented at a rate of 80 digits
per minute, and to press a response button whenever they saw either
three consecutive odd or three consecutive even digits. There were
eight such target strings of digits in each one-minute block. The
number of correct detections of targets (‘hits’) was recorded within a
1500 ms window following the onset of the third digit in the target
sequence. The average latency of correct detections (ms) and the
number of false alarms (responses to non-targets) were also recorded.
This test was performed four times during the testing session: twice at
the beginning of the testing session (practice-a and practice-b runs),
once at the pre-smoking baseline (baseline run) and once at the post-
smoking time point (post-smoking run).
2.4. Experimental procedure
Volunteers reported to the University of Brighton Psychophar-
macology Laboratory having been asked to abstain from smoking for
a minimum of 2 h (actual abstinence varied between 2 and 96 h,
mean±SEM: 12.1±2.4 h). After completing the Smokerlyzer test
Table 1
Demographic characteristics and salivary cotinine levels of the two nicotine
dependence groups, based on the Fagerström Tolerance Questionnaire (FTQ) score.
Values represent means (±SEM). DUQ scoring: 0=never used, 1=not used in the last
month, 2=used once in the last month, 3=used 2–5 times in the last month, 4=used
6–10 times in the last month, 5=used more than 10 times in the last month.
n=24 per group
(12 male, 12 female)
Low-dependent
smokers [LD]
High-dependent
smokers [HD]
t[46]
Age (years) 24.0 (0.7) 22.6 (0.5) 1.68
No. of cigarettes/day 6.8 (0.9) 16.2 (1.4) −5.76⁎⁎⁎
FTQ score 3.4 (0.2) 6.0 (0.3) −8.52⁎⁎⁎
No. of years smoking regularly 5.5 (0.6) 7.1 (0.5) −2.15⁎
Time since last cigarette (h) 18.1 (4.4) 6.2 (1.0) 2.62⁎
Salivary cotinine at baseline
(ng/ml)†
9.5 (2.6) 32.0 (8.0) −2.67⁎
Alcohol use (units/week) 30.0 (3.6) 37.4 (6.8) −.96
DUQ — Amphetamines 0.3 (0.1) 0.6 (0.2) −1.34
DUQ — Cocaine 0.5 (0.2) 0.7 (0.2) −.99
DUQ — Ecstasy (MDMA) 0.5 (0.1) 0.9 (0.2) −1.47
DUQ — Hallucinogen 0.3 (0.1) 0.6 (0.1) −1.94
DUQ — Opiate 0.1 (0.1) 0.1 (0.1) .51
DUQ — Cannabisa 1.8 (0.2) 2.1 (0.3) −.70
a DUQ scoring for cannabis: 0=never smoked, 1=not smoked in the last month,
2=smoked once in the last month, 3=smoked≤once a week in the last month,
4=smoked several times a week in the last month, 5=smoked every day in the last
month.
⁎ pb .05.
⁎⁎⁎ pb .001 (independent t-tests).
† n=14 LD, 21 HD.
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purpose of both measures was to verify compliance), volunteers
were asked to perform the RVIP task twice (practice-a and practice-
b runs), with a 10-minute break between the tests, in order to
familiarize themselves with the task. Following this and thirty
minutes after their arrival to the laboratory, volunteers performed
the Smokerlyzer test again followed by the baseline test battery
which consisted of nicotine-VAS, QSU, POMS and RVIP (time point:
baseline). The experimenter then accompanied the volunteers
individually to another room where half were instructed to smoke
one of their cigarettes and half remained abstinent but spent a
similar period of time in the room. Upon returning to the testing
room, volunteers performed the Smokerlyzer test and the second
test battery consisting of nicotine-VAS, QSU, POMS, RVIP and IED
(time point: post-smoke) followed by the demographic question-
naire. Volunteers were then debriefed about the purpose of the
study, paid for their participation and were allowed to leave the
laboratory.
2.5. Data analyses
Demographic data, duration of abstinence, baseline breath CO and
salivary cotinine levels of the four experimental groups were analyzed
using univariate analysis of variance (ANOVA) with FTQ group (LD vs.
HD) and smoking condition (NS vs. S) as between-subjects factors.
The effects of the smoking manipulation on subjective measures as
well as on breath CO levels were evaluated using repeated-measures
ANOVA with FTQ group and smoking condition as the between-
subject factors and time point (baseline vs. post-smoking) as the
within-subject factor. IED data were analyzed using univariate
ANOVA, with FTQ group and smoking condition as between-subject
factors. All signiﬁcant interactions from repeated measures ANOVA
were explored using appropriate post-hoc t-tests while signiﬁcant
interactions observed in the univariate ANOVA of IED data were
explored using Tukey's HSD test in order to minimize the occurrence
of type 1 error resulting from multiple comparisons.
RVIP data were analyzed twice using repeated-measures ANOVA
with FTQ group and smoking condition as the between-subject factors
and time as the within-subject factor. The ﬁrst ANOVAwas performed
in order to evaluate the effects of the smoking manipulation thus the
within-subject factor time had only two levels (baseline vs. post-
smoke). The second ANOVA of RVIP data was performed post-hoc in
order to evaluate the development of a practice effect and thus the
within-subject factor time had four levels (practice-a vs. practice-b vs.
baseline vs. post-smoking). Since the distribution of response
latencies on RVIP usually shows positive skewness, natural log
transformation was applied to normalize these data prior to analyses.
Where the sphericity assumption of repeated measures ANOVA was
violated, Huynh–Feldt correction was applied. Signiﬁcant main effects
and interactions observed in the second ANOVA of RVIP data (four
time points) were analyzed using simple contrasts vs. practice-a run.
This analysis was chosen instead of a series of t-test as it was deemed
to be the most appropriate way to evaluate the occurrence of a
practice effect across the four runs.
To further explore the nicotine dependence level of the present
experimental sample, a series of linear correlations of baseline
physiological and self-report measures was performed.
Holme's correction was applied to the results of the correlations as
well the results of ANOVAs on several factors from the same
questionnaire, in order to reduce the likelihood of familywise type 1
error. The adjusted signiﬁcance level (α′) is calculated by dividing the
standard signiﬁcance level (α=.05) by the number of comparisons
performed (c): α′=α /c. We have decided against applying correc-
tions for multiple comparisons when doing post-hoc t-tests and
contrast analyses as this was a simple 2×2 design (2×2×2 for the
subjective effect and RVIP variables which were measured before andafter the smoking manipulation) and such corrections are not
recommended for exploration of signiﬁcant interactions which
involves ﬁve or less planned post-hoc comparisons (Roberts and
Russo, 1999).
All statistical analyses were performed using SPSS 15.0.3. Results
3.1. Population characteristics
The four experimental groups werematchedwith respect to age as
well as alcohol and other drug use (FTQ group×smoking condition Fs
[1,44]b3.78, n.s.). A main effect of FTQ group was revealed for several
demographic variables, with HD group having higher FTQ scores,
smoking more cigarettes per day, being regular smokers for greater
number of years, and reporting shorter duration of abstinence than
the LD group (Fs[1,44]N4.65, psb .05). Demographic characteristics of
the two FTQ groups are presented in Table 1.
Salivary cotinine levels ranged between 1.07–29.80 ng/ml in the
LD group and 1.87–124.96 ng/ml in the HD group. ANOVA revealed a
main effect of FTQ group, with HD having higher salivary cotinine
levels than LD volunteers (F[1,31]=5.522, pb .05; Table 1). Analysis of
baseline CO levels also revealed a main effect of FTQ group, with LD
having lower CO levels than HD (F[1,44]=6.182, pb .05; Table 1).
Several signiﬁcant correlations were observed between number of
cigarettes per day, FTQ score, number of years smoking regularly,
duration of abstinence, baseline breath CO levels and salivary cotinine.
Most correlations remained signiﬁcant after the Holme's correction
(α′=.0033 and α′=.0056 for the largest and the smallest signiﬁcant
effect, respectively; Table 2).
In order to control for the potentially confounding inﬂuence that
the variable duration of abstinencemay have had on the experimental
outcomemeasures, time since last cigarette was entered as a covariate
in all subsequent ANOVAs. The results of these analyses of covariance
(ANCOVAs) will be reported only when they differed from the results
of the original ANOVAs, otherwise only the ANOVA results will be
reported here.
Table 2
Correlations between self-report and physiological measures of nicotine dependence and abstinence. Values represent Pearson's r.
n=48 No. of cigarettes/
day
FTQ score No. of years
smoking regularly
Time since last
cigarette (h)
Breath CO
(ppm)
Salivary cotinine
(ng/ml)
No. of cigarettes/day
FTQ score .77⁎⁎
No. of years smoking regularly .36 .41⁎⁎
Time since last cigarette (h) -.39⁎⁎ -.29 -.01
Breath CO (ppm) .57⁎⁎ .54⁎⁎ .45⁎⁎ -.37
Salivary cotinine (ng/ml)† .50⁎⁎ .65⁎⁎ .28 -.32 .68⁎⁎
**pb .01 (signiﬁcant after Holme's correction). † n=35.
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3.2.1. Breath CO level
The ANOVA of change in breath CO levels after the smoking
manipulation revealed a signiﬁcant 2-way interaction of smoking
condition and time point (F[1,44]=133.85, pb .001). Post-hoc t-tests
revealed that breath CO signiﬁcantly increased in the S condition
(t[23]=−11.01, pb .001) and declined in the NS condition (t[23]=
4.51, pb .001) so that at the post-smoking time point levels were
signiﬁcantly higher in the S, compared to the NS group (t[46]=−2.84,
pb .01). While breath CO levels remained higher in the HD group
throughout the experiment (main effect of FTQ group: F[1,44]=5.92,
pb .05), this main effect was no longer signiﬁcant in the ANCOVA
controlling for the duration of abstinence (F[1,43]=2.61, pN .10). The
3-way interaction of FTQ group, smoking manipulation and time
point did not reach statistical signiﬁcance (F[1,44]=.24, n.s.),
suggesting that the two FTQ groups did not differ in terms of the
amount of smoke inhaled during the smoking manipulation. Breath
CO levels of the four experimental groups at both time points are
presented in Table 3.
3.3. Subjective effects
Interaction of smoking condition and time point was observed
forNic-VAS ratings of ‘Buzzed’ and ‘Dizzy’ (F[1,44]=13.322, pb .001 and
F[1,44]=9.47, pb .005, respectively — Fig. 1a and b) as well as for both
QSU factors (factor 1: F[1,44]=49.74, pb .001; factor 2: F[1,44]=14.81,
pb .001; Fig. 2). Smoking signiﬁcantly increased Nic-VAS ratings of
‘Buzzed’ and ‘Dizzy’ (t[23]=−4.54, pb .001 and t[23]=−4.28, pb .001,
respectively) and decreased QSU scores (factor 1: t[23]=7.21, pb .001;
factor2: t[23]=4.11, pb .001),while ratings remainedunchanged in the
abstinent group (psN .30).
In addition, several main effects of FTQ group were observed.
Compared to LD, HD group had lower scores for POMS factors ‘Vigour’,
‘Friendliness’ and ‘Elation’ (F[1,44]=14.96, pb .001, F[1,44]=14.76,
pb .001 and F[1,44]=10.69, pb .005, respectively; Fig. 1c, d and e) asTable 3
Breath CO levels (ppm) of low- [LD] and high-dependent smokers [HD] allocated to the
smoking [S] or the abstinent [NS] condition. Measurements were taken at baseline [T1]
and after the smoking manipulation [T2]. Values represent means (±SEM).
n=12 per group
(6 m, 6f)
T1# T2#
S LD 2.8
(1.2)
6.7
(1.4)
⁎⁎⁎
⁎⁎
HD 8.3
(1.7)
12.3
(1.8)
NS LD 5.2
(1.4)
4.4
(1.3)
⁎⁎⁎
HD 6.8
(1.5)
5.7
(1.2)
# pb .05 (main effect of the nicotine dependence group – LD vs. HD).
⁎⁎⁎ pb .001 (independent t-tests vs. T1).
⁎⁎ pb .01 (independent t-test vs. NS condition).well as higher scores for both QSU factors (factor 1: F[1,44]=13.23,
pb .001; factor 2: F[1,44]=8.02, pb .01; Fig. 2.).
Three-way interaction of time point, smoking condition and FTQ
group did not reach statistical signiﬁcance for any of the subjective
measures (Fs[1,44]b3.60, psN .06).3.4. Cognitive effects
3.4.1. IED
The majority of participants (LD: 87.5%, HD: 91.7%) successfully
completed all nine stages of the test. ANOVAs of IED variables revealed
a signiﬁcant interaction of FTQ group and smoking condition for the
number of the intra-dimensional (ID) set-shift errors (F[1,43]=11.86,
pb .001; Table 4). Post-hoc Tukey's HSD test revealed that HD smokers
in the smoking (S) condition made signiﬁcantly more errors than HD
smokers in the abstinent (NS) condition (pb .01). All other compar-
isons were not signiﬁcant. Mean values (±SEM) of IED outcome
measures of the four experimental groups are presented in Table 4.
Since the number of intra-dimensional errors made by the
majority of participants was relatively low, one sample t-tests from
0 were performed in each of the four experimental groups to verify
that the observed interaction was unlikely to be a mere statistical
artifact due to extreme values. All groups apart from the HD smokers
in the abstinent condition made a signiﬁcant number of errors
compared to zero (HD-S: t[11]=4.75, pb .001; LD-NS: t[11]=4.69,
pb .001; LD-S: t[10]=2.39, pb .05), conﬁrming the validity of the
interaction.3.4.2. RVIP
Smoking did not signiﬁcantly modulate any aspect of RVIP
performance (Fs[1,44]b2.65, psN .10). However, when the two
practice runs were included in the ANOVA together with the baseline
and post-smoke runs, a signiﬁcant main effect of time was revealed
for hits (Huynh–Feldt F[2.64, 116.35]=28.62, pb .001) and false
alarms (Huynh-Feldt F[2.08, 91.42]=9.20, pb .001) indicating a
steady improvement in RVIP performance across all four runs
(simple contrasts vs. practice-a run: FsN35.24, psb .001 for hits and
FsN11.37, psb .005 for false alarms). Response latencies similarly
improved and were signiﬁcantly lower at the post-smoking time
point compared to the ﬁrst practice run (main effect of time: Huynh–
Feldt F[2.89, 127.33]=4.93, pb .005; simple contrast post-smoke vs.
practice-a run: F[1,44]=10.12, pb .005). Additionally, an interaction
of the FTQ group and time pointwas observed for hits (Huynh–Feldt F
[2.64, 116.35]=3.56, pb .05). This interaction reﬂected a signiﬁcant-
ly greater rate of improvement in the LD group between the ﬁrst
practice run and the pre-smoking baseline (simple contrast vs.
practice-a run: F[1,44]=8.05, pb .01), and this difference was also
maintained at the post-smoking time point (simple contrast vs.
practice-a run: F[1,44]=4.36, pb .05). Mean values (±SEM) of RVIP
variables in LD and HD groups across the four runs are presented in
Table 5.
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Fig. 1. Effects of smoking manipulation (NS-abstinent, S-smoking) on Nic-VAS ratings of a) ‘Buzzed’ and b) ‘Dizzy’ and POMS ratings of c) ‘Vigour’, d) ‘Friendliness’ and e) ’Elation’ in
low-dependent [LD] and high-dependent [HD] smokers. Measurements taken at baseline [T1] and after the smoking manipulation [T2]. N=48. *** pb .001 (T1 vs. T2; paired t-test
within S group); ## pb .01, ### pb .001 (main effect of FTQ group, LD vs. HD).
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The present study demonstrated an acute smoking-induced deﬁcit
in cognitive ﬂexibility (more errors during the intra-dimensional
shift). This effect, however, was not detected in the entire exper-
imental sample but only in individuals with a greater degree of
dependence (Fig. 3). Although the higher cotinine (and therefore
nicotine) levels inherent in the HD group might have inﬂuenced the
effect of smoking manipulation on cognitive ﬂexibility, it is clear from
the craving data that the HDs, like LDs, were nevertheless in
withdrawal and, in fact, their craving in the absence of smoking was
higher than that observed in the LD smokers. It could therefore be
speculated that smoking is of such an incentive salience for the HD
smokers (because of their high dependence) that this reduces the
attentional recourses required for the cognitive ﬂexibility.
The ﬁnding of smoking-induced deterioration in cognitive ﬂexibility
in more dependent smokers contrasts with the previous studies whichdid not detect an effect of smoking or nicotine patch on cognitive
ﬂexibility in samples of heavy smokers (Rotheram-Fuller et al., 2004;
Mancuso et al., 1999). However, although the participants in the
Rotheram-Fuller et al. study tended to smoke more heavily (N20
cigarettes per day) than the HD smokers in the present study, theywere
abstinent only for 30 min,whichmayhave reduced their vulnerability to
further smoking-induced deterioration of cognitive ﬂexibility. Thus
longer abstinence (minimum two hours in the present study) may be
crucial in order to detect acute effects of smoking on cognitive ﬂexibility
in high-dependent smokers. In addition, the present study has a number
of advantages over the previous ones. In comparison to the Mancuso
et al. (1999) study, this study involved a more speciﬁc measure of
attentional set-shifting as well as a more rapid route of nicotine
administration (smoking, as opposed to a nicotine patch). Furthermore,
Rotheram-Fuller et al. (2004) study includedonly19participants in their
non-opiate-dependentgroupof smokers and thus had lowerpower than
the present study to detect the effects of smoking on cognitiveﬂexibility.
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Fig. 2. Effects of smoking manipulation (NS-abstinent, S-smoking) on a) QSU factor 1
(positive reinforcement) and b) QSU factor 2 (negative reinforcement) in low-
dependent [LD] and high-dependent [HD] smokers. Measurements taken at baseline
[T1] and after the smoking manipulation [T2]. N=48. *** pb .001 (T1 vs. T2; paired t-
test within S group); ## pb .01, ### pb .001 (main effect of FTQ group, LD vs. HD).
Table 4
IED test performance of low- [LD] and high-dependent smokers [HD] allocated to the
smoking [S] or the abstinent [NS] condition. Test was performed after the smoking
manipulation. Values represent means (±SEM).
n=12 per group (6 m, 6f) NS S
Number of stages completed LD 8.8 (0.2) 8.6 (0.4)
HD 9.0 (0) 8.7 (0.2)
Total number of errors
(adjusted for the stages not completed)
LD 17.8 (4.0) 23.3 (10.1)
HD 11.7 (1.6) 22.3 (5.2)
Number of errors in stage 1
(discrimination learning)
LD 0.2 (0.1) 0.2 (0.2)
HD 0.0 (0.0) 0.4 (0.2)
Number of errors in stage 2
(simple reversal learning)
LD 1.4 (0.2) 1.2 (0.1)
HD 1.5 (0.4) 1.2 (0.1)
Number of errors in stage 3
(new dimension introduced but ignored)
LD 1.8 (0.9) 2.1 (0.9)
HD 1.4 (0.3) 4.2 (1.9)
Number of errors in stage 4
(new dimension still ignored)
LD 0.6 (0.3) 0.3 (0.2)
HD 0.3 (0.1) 0.5 (0.2)
Number of errors in stage 5
(reversal, still ignoring the new dimension)
LD 1.3 (0.1) 3.1 (2.0)
HD 1.3 (0.2) 1.1 (0.2)
Number of errors in stage 6
(intra-dimensional set-shift)
LD 0.7 (0.1) 0.4 (0.2)†
HD 0.2 (0.1) 0.9 (0.2)⁎⁎
Number of errors in stage 7
(reversal, still ignoring the new dimension)
LD 1.4 (0.3) 1.1 (0.1)†
HD 1.6 (0.4) 1.3 (0.2)
Number of errors in stage 8
(extra-dimensional set-shift)
LD 5.3 (1.9) 4.5 (1.3)†
HD 4.3 (1.6) 7.0 (2.7)
Number of errors in stage 9
(reversal, still attending to the new dimension)
LD 3.5 (2.0) † 3.1 (1.8)†
HD 1.2 (0.1) 1.9 (0.6)††
Reversal learning
(errors in stages 2+5+7+9)
LD 7.6 (2.2) † 6.4 (1.7)†
HD 5.6 (0.5) 5.5 (0.6)††
Attentional ﬂexibility
(errors in stages 6+8)
LD 5.9 (1.8) 4.8 (1.2)†
HD 4.4 (1.6) 7.9 (2.6)
† N=11.
†† N=10.
⁎⁎ pb .01 (Tukey's HSD test vs. HD-NS group).
Table 5
RVIP hits, false alarms and response latencies of low- [LD] and high-dependent smokers
[HD] at practice-a run 1 [P-a], practice-b run [P-b], pre-smoking baseline [T1] and after
the smoking manipulation [T2]. Values represent means (±SEM). Main effects of time
point: ** pb .01, *** pb .001— simple contrast vs. P1. Time point×FTQ group interaction:
# pb .05, ## pb .01 — simple contrast vs. P1.
n=24 per group (12 m, 12f) FTQ group P-a P-b T1 T2
RVIP — number of hits (max. 40)
*** (P2, T1, T2)
LD 24.5
(1.7)
29.8
(1.7)
32.4 ##
(1.1)
32.3 #
(1.1)
HD 26.5
(1.7)
29.1
(1.6)
29.9
(1.9)
30.5
(1.9)
RVIP — number of false alarms
*** (P2), ** (T1, T2)
LD 3.3
(0.8)
1.8
(0.4)
1.7
(0.4)
1.2
(0.2)
HD 2.9
(0.8)
1.3
(0.4)
1.4
(0.4)
1.5
(0.6)
RVIP — response latencies (ms)
** (T2)
LD 537.2
(14.9)
526.0
(17.6)
521.6
(15.9)
500.2
(16.9)
HD 508.2
(15.0)
497.8
(17.4)
505.9
(17.0)
482.1
(16.5)
382 J. Nesic et al. / Pharmacology, Biochemistry and Behavior 98 (2011) 376–384The lack of signiﬁcant difference in cognitive ﬂexibility between
abstinent HD and LD smokers is not in line with the results of previous
correlational studies (heavier smokers display lower cognitive
ﬂexibility; e.g. Martin et al., 2000; Kalmijn et al., 2002) as well as
studies of abstinent drug users (reduced cognitive ﬂexibility com-
pared to non-drug using controls; Verdejo-Garcia et al., 2004, 2005,
2006; Kim et al., 2005; von Geusau et al., 2004; Ornstein et al., 2000).
It is not clear, however, why the smoking-induced impairment
occurred selectively in HD but not in LD smokers and future
neuroimaging studies should investigate the effect of smoking on
brain activation of LD and HD smokers during the performance of a
cognitive ﬂexibility test in order to further elucidate the present
ﬁndings.
It is important to note that the effects of smoking dependence level
and of the acute smoking manipulation were observed only for the
intra-dimensional set-shift and not for the extra-dimensional set-shift,
which is generallymore difﬁcult to perform as it requires participants to
overcome their acquired bias in order to attend to the previously
ignored dimension (Rogers et al., 2000). Successfully performing an
intra-dimensional shift is a reﬂection of whether an individual was able
to develop attentional bias for the reinforced dimension by generalizing
a discrimination learned for a particular set of stimuli to another set
from the same dimension. While schizophrenic patients (Pantelis et al.,
1999), heroin addicts (Ornstein et al., 2000) as well as binge drinkers
(Scaife and Duka, 2009) have shown selective impairment in intra-
dimensional set-shift ability, neuropsychological as well as neuroima-
ging studies suggest that this ability does not depend solely on pre-
frontal cortical activation (e.g. Rogers et al., 2000; Owen et al., 1991;
Pantelis et al., 1999). Future studies need to focus on clarifying the originof this speciﬁc deﬁcit as well as its’ relevance to the phenomenon of
smoking dependence.
TheRVIP testwas included in thepresent study as a control cognitive
task known to be sensitive to the effects of nicotine. The lack of the effect
of smoking on RVIP performance in the present study is thus in contrast
with other studies which demonstrated sensitivity of this test to
nicotine manipulations (Warburton and Arnall, 1994; Foulds et al.,
1996; Jackson et al., 2009) although negative results using this test have
also been reported (Herbert et al., 2001). There was, however, a steady
improvement in RVIP performance over the course of the present study
(progressive increase in the number of hits and a decrease in the
number of false alarms as well as a progressive reduction in response
latencies) and it is possible that the effects of smoking in one or both of
the nicotine dependence groups would have become apparent if the
RVIP test had not beenover-practiced over such a short period of time. It
is interesting to note that the rate of improvement in RVIP test
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Fig. 3. Effects of smoking manipulation (NS-abstinent, S-smoking) on intra-dimensional
set-shift performance in low-dependent [LD] and high-dependent [HD] smokers.
Measurements taken and after the smokingmanipulation [T2]. N=48. ** pb .01 (unpaired
t-test S vs. NS within the HD group).
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continuous performance tests such as RVIP involve an element of
executive control (maintaining and updating information in the
working memory and inhibition of processing of and responding to
non-target stimuli; see Clark and Goodwin, 2004, for discussion) which
can be improved by training (e.g. Persson and Reuter-Lorenz, 2008;
Chen et al., 1998), the present ﬁnding may suggest that heavy smoking
reduces the plasticity which is thought to underlie such practice effects
(Westerberg and Klingberg, 2007). This ﬁnding thus extends the
previous report of dose- and duration-related smoking-induced
memory impairment in young smokers (Fried et al., 2006).
In both groups of smokers in the present study, smoking induced
an increase in subjective ratings of ‘Buzzed’ and ‘Dizzy’ as well as a
decrease in the positive and the negative reinforcement aspects of
craving for cigarettes. However, throughout the experimental session,
less dependent smokers tended to report less craving for cigarettes
compared to the more heavily dependent smokers as well as to feel
more vigorous, friendly and elated. Greater vigor has been related to
better cognitive performance measured by mental arithmetics and
logical memory (Deary and Tait, 1987) and it is thus possible that the
increased vigor seen in LD smokers is related to their lower
susceptibility to smoking-induced impairment in cognitive ﬂexibility.
The present ﬁndings of mood differences, together with the ﬁnding of
reduced practice effect on RVIP in HD smokers, suggest that LD and
HD smokers are indeed two distinct populations. This emphasizes the
need for separating low- from high-dependent smokers in experi-
mental studies of cognitive function.
As personality traits constitute susceptibility to smoking depen-
dence (e.g. Lipkus et al., 1994), it would be interesting for future
studies to examine in more depth the personality characteristics of
the two populations of smokers (LD and HD) as this may hold the key
both to the difference in their susceptibility to smoking dependence
and to the effects of acute smoking on their cognitive function. For
instance, a positron-emission tomography (PET) study by Fallon et al.
(2004) demonstrated that application of a 21-mg nicotine patch
produces no changes in brain activation in low-hostile smokers but
induces a widespread decrease in cortical activation in high-hostile
smokers. As high hostility is thought to be one of the personality traits
associated with susceptibility to nicotine addiction (Lipkus et al.,
1994), it would be important to evaluate whether this personality
factor also mediates the cognitive effects of smoking on cognitive
ﬂexibility.
The difference between LD and HD groups in the number of hours
since they last smoked was not related to any of the cognitive or the
subjective effect differences between these two groups (inclusion of the
duration of abstinence as a covariate did not alter the results of the
analyses). This suggests that the present ﬁndings are likely to be due totrait and/or chronic nicotine exposure-induced differences between the
more dependent and the less dependent smokers and not related to the
recent level of nicotine exposure. Although it is possible that higher
circulating levels of nicotine in HD smokers (indicated by higher breath
CO and cotinine levels) may have contributed to the subjective and
cognitive effects observed in the present study, this is likely to be an
inherent part of the division between the LD and HD smokers (LD
smokers chose to abstain for longer) and it was thus deemed
unnecessary to include these variables as covariates in the analyses
(see Miller and Chapman, 2001 for a discussion of inappropriateness of
covarying for differences which are inherent in group membership).
One of the limitations of the present study is that the between-
subjects design employed in the present study does not allow a
conclusive comparison of individuals' performance under abstinent
and satiated conditions and further studies, employing a within-
subjects design, are needed to replicate and elucidate this result.
Furthermore, a study comparing abstinent and satiated LD and HD
smokers to a control group of non-smokers is necessary to investigate
whether the effect of acute and chronic tobacco use on cognitive
ﬂexibility is indeed linear and varies directly with the degree of
dependence. Inclusion of a smoking control procedure administered
in a double-blind manner would also help elucidate the ﬁndings from
the present study. However, the aim of the present study was to
evaluate the cognitive and subjective effects of smoking (and this
includes the pharmacological effects of nicotine together with
conditioned responses and expectancies) in two populations of
smokers who differ with respect to their need for (i.e. dependence
on) smoking. Therefore the sham smoking or the denicotinized
smoking procedureswould be the only options yet these also fall short
as adequate controls for smoking in a smoking population.
A further limitation is that IQ was not directly assessed in the
present study and, although all participants came from a fairly homo-
genous population of University students and employees, the
possibility of IQ differences between the groups cannot be excluded
as a factor contributing to the observed effects. Future studies of
cognitive ﬂexibility in smokers should thus control for participants' IQ
as a source of variance. Finally, considering the sensitivity of PFC-
dependent cognitive functions to circulating levels of sex-related
hormones (e.g. Hatta and Nagaya, 2009), another limitation of the
present study is that the phase of menstrual cycle of female partici-
pants was not controlled for. In order to minimize the hormone-
related variability of the data, future studies should include female
participants only during the early follicular phase (days 2–4) of the
menstrual cycle or those who are taking oral contraceptives.
In summary, inﬂuence of smoking on cognitive ﬂexibility varies
according to the degree of dependence. In abstinence, HD smokers
appear to have greater cognitive ﬂexibility than LD smokers. However,
this difference was reversed by smoking, which selectively impaired
cognitive ﬂexibility of HD smokers.
It is not clear whether the difference between the LD and the HD
smokers in their sensitivity to the smoking-induced impairment of
cognitive ﬂexibility is the cause or the consequence of their dif-
ferential level of dependence. However, the present study demon-
strates that the variability in nicotine-dependence levels within the
experimental sample may obscure any effects of acute smoking which
may be apparent only in the more dependent smokers and only after
several hours of abstinence. Dependence levels should therefore be
taken into account as a factor in studies assessing the acute as well as
chronic cognitive effects of smoking.
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